← FDA DRUG APPROVALS

FDA ANDA · ANDA073421

NIFEDIPINE

Sponsor: CHASE LABS NJ

APPLICATION
ANDA073421
TYPE
ANDA
ORIGINAL APPROVAL
1991-06-19
LATEST ACTION
1992-08-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

NIFEDIPINEDiscontinued
NIFEDIPINE 20MG · CAPSULE · ORAL

Approval history

1992-08-06Labeling · Supplement 8AP
1992-04-16Labeling · Supplement 6AP
1991-06-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →